ITEMS IN AFP WITH KEYWORD:
Misoprostol alone was associated with a nearly 80% success rate in the first trimester of pregnancy on meta-analysis.
Jul 1, 2019 Issue
Preventing Spontaneous Abortion with Progestin Therapy [Medicine by the Numbers]
The use of progestin therapy in women with recurrent pregnancy loss appears to reduce the incidence of spontaneous abortion, preterm labor, and stillbirth, and increase the rate of live birth. However, due to issues with the studies the authors were hesitant to give progestin their full support. Find out more.
Two percent of women will develop a Bartholin duct cyst or gland abscess in their lifetime, and physicians should be familiar with the range of treatment options. Find out which procedures are most effective, how to make a ring catheter in the office, and when to refer patients to a gynecologist for lesion excision.
Abnormal uterine bleeding is a common symptom in reproductive-aged women. Learn how the acronym PALM-COEIN can help classify bleeding, and find out how to tell which patients can be managed medically and which ones are candidates for surgery.
What are the comparative effectiveness and harms of treatments for uterine fibroids, and what is the risk of finding unexpected leiomyosarcoma in women with fibroids?
The differential diagnosis includes threatened abortion, early pregnancy loss, and ectopic pregnancy. Guidelines are available to decrease the likelihood of falsely diagnosing a nonviable pregnancy and of intervening in a desired viable pregnancy. Find out which patients can be managed expectantly and which ones should be treated medically or surgically.
Prasterone is similarly effective to nonprescription options for treating vaginal dryness and itching associated with menopause and may offer a small benefit in the treatment of dyspareunia.
In women with early pregnancy loss between five and 12 weeks' gestation, pretreatment with 200 mcg of oral mifepristone before 800 mcg of vaginal misoprostol increases the likelihood of successful expulsion of the gestational sac.
A women presented with worsening cramps and lower abdominal pain six weeks after starting medroxyprogesterone acetate (Depo-Provera). The discomfort subsided after she vaginally passed a bloody fleshy mass.
FGM/C involves partial or total removal of the external genitalia or other injury to the female genital organs for nonmedical reasons. It is considered a human rights violation. It has no known health benefits, but many reported harmful consequences.